Literature DB >> 811126

Isolation, identification, and biological characterization of Acanthamoeba polyphaga from a human eye.

G S Visvesvara, D B Jones, N M Robinson.   

Abstract

Trophozoites and cysts of an Acanthamoeba were repeatedly isolated from the corneal scrapings of a patient suffering from acute ulceration of the right eye. The ameba was cloned and cultivated axenically in a proteose peptone-yeast extract-glucose medium. At a later date the organism was identified as A. polyphaga on the basis of its morphologic characteristics, especially those of cysts. Experimental studies on the in vitro interaction of this organism with monkey kidney tissue culture (Vero line) and its pathogenicity to mice indicated that it was a low virulent strain. When large numbers of amebae (25,000+) were inoculated into Vero cell cultures, cytopathic effects (CPE) were noticed within 5 to 6 days. The CPE consisted of cell shrinkage, nuclear pyonosis, and discontinuity of cell sheet, and the cell culture was totally destroyed in 8 to 10 days. When 20,000+ amebae were instilled intranasally into each of 20 2-week-old mice, only 1 mouse died, on the 28th day. Amebae were isolated from the brain of the dead mouse, and trophozoites and cysts were also demonstrated in the brain sections. When amebae isolated from the brain were intranasally instilled into mice, they failed to kill the mice for at least 1 month; however, when 10,000+ amebae were inoculated intracerebrally, the mice died within 5 to 8 days, exhibiting symptoms of primary meningoencephalitis.

Entities:  

Mesh:

Year:  1975        PMID: 811126     DOI: 10.4269/ajtmh.1975.24.784

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  15 in total

1.  Differentiation of Acanthamoeba strains from infected corneas and the environment by using restriction endonuclease digestion of whole-cell DNA.

Authors:  S Kilvington; J R Beeching; D G White
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

2.  Differentiation of Naegleria fowleri from Acanthamoeba species by using monoclonal antibodies and flow cytometry.

Authors:  B M Flores; C A Garcia; W E Stamm; B E Torian
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

3.  Acanthamoeba keratitis: risk factors and outcome.

Authors:  C D Illingworth; S D Cook; C H Karabatsas; D L Easty
Journal:  Br J Ophthalmol       Date:  1995-12       Impact factor: 4.638

4.  Growth characteristics, cytopathic effect in cell culture, and virulence in mice of 36 type strains belonging to 19 different Acanthamoeba spp.

Authors:  J F De Jonckheere
Journal:  Appl Environ Microbiol       Date:  1980-04       Impact factor: 4.792

5.  Soil amebae in Canada.

Authors:  T Scholten
Journal:  Can Med Assoc J       Date:  1979-02-03       Impact factor: 8.262

6.  Riboflavin and ultraviolet A as adjuvant treatment against Acanthamoeba cysts.

Authors:  Ricardo Lamy; Elliot Chan; Samuel D Good; Vicky Cevallos; Travis C Porco; Jay M Stewart
Journal:  Clin Exp Ophthalmol       Date:  2016-02-23       Impact factor: 4.207

7.  Killing acanthamoebae with polyaminopropyl biguanide: quantitation and kinetics.

Authors:  R M Burger; R J Franco; K Drlica
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

8.  Laboratory investigation of Acanthamoeba keratitis.

Authors:  S Kilvington; D F Larkin; D G White; J R Beeching
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

9.  Diagnosis of infections caused by pathogenic free-living amoebae.

Authors:  Bruno da Rocha-Azevedo; Herbert B Tanowitz; Francine Marciano-Cabral
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-02

10.  National outbreak of Acanthamoeba keratitis associated with use of a contact lens solution, United States.

Authors:  Jennifer R Verani; Suchita A Lorick; Jonathan S Yoder; Michael J Beach; Christopher R Braden; Jacquelin M Roberts; Craig S Conover; Sue Chen; Kateesha A McConnell; Douglas C Chang; Benjamin J Park; Dan B Jones; Govinda S Visvesvara; Sharon L Roy
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.